Engineering Antigen-Specific Tolerance to an Artificial Protein Hydrogel

Peter B. Rapp,Joshua A. Baccile,Rachel P. Galimidi,Jost Vielmetter
DOI: https://doi.org/10.1021/acsbiomaterials.3c01430
2024-03-13
ACS Biomaterials Science & Engineering
Abstract:Artificial protein hydrogels are an emerging class of biomaterials with numerous prospective applications in tissue engineering and regenerative medicine. These materials are likely to be immunogenic due to their frequent incorporation of novel amino acid sequence domains, which often serve a functional role within the material itself. We engineered injectable "self" and "nonself" artificial protein hydrogels, which were predicted to have divergent immune outcomes <i>in vivo</i> on the basis of their primary amino acid sequence. Following implantation in mouse, the nonself gels raised significantly higher antigel antibody titers than the corresponding self gels. Prophylactic administration of a fusion antibody targeting the nonself hydrogel epitopes to DEC-205, an endocytic receptor involved in T<sub>reg</sub> induction, fully suppressed the elevated antibody titer against the nonself gels. These results suggest that the clinical immune response to artificial protein biomaterials, including those that contain highly antigenic sequence domains, can be tuned through the induction of antigen-specific tolerance.
materials science, biomaterials
What problem does this paper attempt to address?